| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:52 UTC |
|---|
| Update Date | 2022-03-07 02:51:58 UTC |
|---|
| HMDB ID | HMDB0015399 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Arformoterol |
|---|
| Description | Arformoterol is a bronchodilator. It works by relaxing muscles in the airways to improve breathing. Arformoterol inhalation is used to prevent bronchoconstriction in people with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. The use of arformoterol is pending revision due to safety concerns in regards to an increased risk of severe exacerbation of asthma symptoms, leading to hospitalization as well as death in some patients using long acting beta agonists for the treatment of asthma. |
|---|
| Structure | COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC(NC=O)=C(O)C=C2)C=C1 InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t13-,19+/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (-)-Formoterol | ChEBI | | (R,R)-Formoterol | ChEBI | | 3-Formylamino-4-hydroxy-alpha-(N-1-methyl-2-p-methoxyphenethylaminomethyl)benzyl alcohol.hemifumarate | HMDB | | Oxis | HMDB | | Formoterol fumarate | HMDB | | BD 40a | HMDB | | Foradil | HMDB | | Formoterol, ((r*,r*)-(+-))-isomer | HMDB | | Eformoterol | HMDB | | Formoterol | HMDB | | Formoterol fumarate, ((r*,r*)-(+-))-isomer | HMDB |
|
|---|
| Chemical Formula | C19H24N2O4 |
|---|
| Average Molecular Weight | 344.4049 |
|---|
| Monoisotopic Molecular Weight | 344.173607266 |
|---|
| IUPAC Name | N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide |
|---|
| Traditional Name | arformoterol |
|---|
| CAS Registry Number | 67346-49-0 |
|---|
| SMILES | COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC(NC=O)=C(O)C=C2)C=C1 |
|---|
| InChI Identifier | InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t13-,19+/m1/s1 |
|---|
| InChI Key | BPZSYCZIITTYBL-YJYMSZOUSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as amphetamines and derivatives. These are organic compounds containing or derived from 1-phenylpropan-2-amine. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Phenethylamines |
|---|
| Direct Parent | Amphetamines and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Amphetamine or derivatives
- Phenylpropane
- Anilide
- Phenoxy compound
- Anisole
- Phenol ether
- N-arylamide
- Methoxybenzene
- Alkyl aryl ether
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Aralkylamine
- Secondary carboxylic acid amide
- Secondary alcohol
- Amino acid or derivatives
- 1,2-aminoalcohol
- Carboxamide group
- Secondary amine
- Carboxylic acid derivative
- Secondary aliphatic amine
- Ether
- Hydrocarbon derivative
- Organonitrogen compound
- Organooxygen compound
- Organic oxygen compound
- Carbonyl group
- Alcohol
- Organic nitrogen compound
- Organopnictogen compound
- Aromatic alcohol
- Organic oxide
- Amine
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | - N-[2-hydroxy-5-(1-hydroxy-2-\{[1-(4-methoxyphenyl)propan-2-yl]amino\}ethyl)phenyl]formamide (CHEBI:408174 )
|
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.042 g/L | Not Available | | LogP | 2.2 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 3.29 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.5953 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.59 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 85.4 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1206.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 188.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 137.5 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 158.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 63.2 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 314.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 367.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 482.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 738.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 273.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 851.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 232.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 251.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 336.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 475.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 51.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Arformoterol,1TMS,isomer #1 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C)C2=CC=C(O)C(NC=O)=C2)C=C1 | 3238.9 | Semi standard non polar | 33892256 | | Arformoterol,1TMS,isomer #2 | COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC=C(O[Si](C)(C)C)C(NC=O)=C2)C=C1 | 3270.5 | Semi standard non polar | 33892256 | | Arformoterol,1TMS,isomer #3 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O)C(NC=O)=C2)[Si](C)(C)C)C=C1 | 3273.9 | Semi standard non polar | 33892256 | | Arformoterol,1TMS,isomer #4 | COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC=C(O)C(N(C=O)[Si](C)(C)C)=C2)C=C1 | 3021.6 | Semi standard non polar | 33892256 | | Arformoterol,2TMS,isomer #1 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(NC=O)=C2)C=C1 | 3194.4 | Semi standard non polar | 33892256 | | Arformoterol,2TMS,isomer #2 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O)C(NC=O)=C2)[Si](C)(C)C)C=C1 | 3213.8 | Semi standard non polar | 33892256 | | Arformoterol,2TMS,isomer #3 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C)C2=CC=C(O)C(N(C=O)[Si](C)(C)C)=C2)C=C1 | 2920.9 | Semi standard non polar | 33892256 | | Arformoterol,2TMS,isomer #4 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O[Si](C)(C)C)C(NC=O)=C2)[Si](C)(C)C)C=C1 | 3264.5 | Semi standard non polar | 33892256 | | Arformoterol,2TMS,isomer #5 | COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)C=C1 | 3038.4 | Semi standard non polar | 33892256 | | Arformoterol,2TMS,isomer #6 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 3013.4 | Semi standard non polar | 33892256 | | Arformoterol,3TMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(NC=O)=C2)[Si](C)(C)C)C=C1 | 3246.8 | Semi standard non polar | 33892256 | | Arformoterol,3TMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(NC=O)=C2)[Si](C)(C)C)C=C1 | 2891.4 | Standard non polar | 33892256 | | Arformoterol,3TMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(NC=O)=C2)[Si](C)(C)C)C=C1 | 3639.8 | Standard polar | 33892256 | | Arformoterol,3TMS,isomer #2 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)C=C1 | 2978.4 | Semi standard non polar | 33892256 | | Arformoterol,3TMS,isomer #2 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)C=C1 | 2660.7 | Standard non polar | 33892256 | | Arformoterol,3TMS,isomer #2 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)C=C1 | 3452.6 | Standard polar | 33892256 | | Arformoterol,3TMS,isomer #3 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 3002.4 | Semi standard non polar | 33892256 | | Arformoterol,3TMS,isomer #3 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 2814.0 | Standard non polar | 33892256 | | Arformoterol,3TMS,isomer #3 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 3615.3 | Standard polar | 33892256 | | Arformoterol,3TMS,isomer #4 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 3050.6 | Semi standard non polar | 33892256 | | Arformoterol,3TMS,isomer #4 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 2878.4 | Standard non polar | 33892256 | | Arformoterol,3TMS,isomer #4 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 3654.3 | Standard polar | 33892256 | | Arformoterol,4TMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 3085.9 | Semi standard non polar | 33892256 | | Arformoterol,4TMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 2735.0 | Standard non polar | 33892256 | | Arformoterol,4TMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C(N(C=O)[Si](C)(C)C)=C2)[Si](C)(C)C)C=C1 | 3382.4 | Standard polar | 33892256 | | Arformoterol,1TBDMS,isomer #1 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O)C(NC=O)=C2)C=C1 | 3498.6 | Semi standard non polar | 33892256 | | Arformoterol,1TBDMS,isomer #2 | COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(NC=O)=C2)C=C1 | 3530.2 | Semi standard non polar | 33892256 | | Arformoterol,1TBDMS,isomer #3 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O)C(NC=O)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3546.0 | Semi standard non polar | 33892256 | | Arformoterol,1TBDMS,isomer #4 | COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC=C(O)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)C=C1 | 3292.6 | Semi standard non polar | 33892256 | | Arformoterol,2TBDMS,isomer #1 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(NC=O)=C2)C=C1 | 3679.4 | Semi standard non polar | 33892256 | | Arformoterol,2TBDMS,isomer #2 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O)C(NC=O)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3753.9 | Semi standard non polar | 33892256 | | Arformoterol,2TBDMS,isomer #3 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)C=C1 | 3415.4 | Semi standard non polar | 33892256 | | Arformoterol,2TBDMS,isomer #4 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(NC=O)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3773.3 | Semi standard non polar | 33892256 | | Arformoterol,2TBDMS,isomer #5 | COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)C=C1 | 3525.0 | Semi standard non polar | 33892256 | | Arformoterol,2TBDMS,isomer #6 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3536.9 | Semi standard non polar | 33892256 | | Arformoterol,3TBDMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(NC=O)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3964.3 | Semi standard non polar | 33892256 | | Arformoterol,3TBDMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(NC=O)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3498.4 | Standard non polar | 33892256 | | Arformoterol,3TBDMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(NC=O)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3811.3 | Standard polar | 33892256 | | Arformoterol,3TBDMS,isomer #2 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)C=C1 | 3646.0 | Semi standard non polar | 33892256 | | Arformoterol,3TBDMS,isomer #2 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)C=C1 | 3155.3 | Standard non polar | 33892256 | | Arformoterol,3TBDMS,isomer #2 | COC1=CC=C(C[C@@H](C)NC[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)C=C1 | 3683.5 | Standard polar | 33892256 | | Arformoterol,3TBDMS,isomer #3 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3738.7 | Semi standard non polar | 33892256 | | Arformoterol,3TBDMS,isomer #3 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3331.6 | Standard non polar | 33892256 | | Arformoterol,3TBDMS,isomer #3 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3805.7 | Standard polar | 33892256 | | Arformoterol,3TBDMS,isomer #4 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3783.2 | Semi standard non polar | 33892256 | | Arformoterol,3TBDMS,isomer #4 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3343.3 | Standard non polar | 33892256 | | Arformoterol,3TBDMS,isomer #4 | COC1=CC=C(C[C@@H](C)N(C[C@H](O)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3862.2 | Standard polar | 33892256 | | Arformoterol,4TBDMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3976.1 | Semi standard non polar | 33892256 | | Arformoterol,4TBDMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3359.3 | Standard non polar | 33892256 | | Arformoterol,4TBDMS,isomer #1 | COC1=CC=C(C[C@@H](C)N(C[C@H](O[Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C(N(C=O)[Si](C)(C)C(C)(C)C)=C2)[Si](C)(C)C(C)(C)C)C=C1 | 3677.7 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Arformoterol GC-MS (Non-derivatized) - 70eV, Positive | splash10-00or-2902000000-10d83ebb89a446028d15 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Arformoterol GC-MS (2 TMS) - 70eV, Positive | splash10-0079-1290400000-a5f812e6f46ebe2c4573 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Arformoterol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 10V, Positive-QTOF | splash10-00mk-0119000000-960431f56a40133b8573 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 20V, Positive-QTOF | splash10-002b-0937000000-93717c858174f9fabf66 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 40V, Positive-QTOF | splash10-0002-0900000000-d7f4b9eb1c7882357173 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 10V, Negative-QTOF | splash10-004l-4209000000-f9910c5b8f497127e7ca | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 20V, Negative-QTOF | splash10-03fu-3619000000-7dd84dcd46e229246839 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 40V, Negative-QTOF | splash10-002f-9400000000-58f5ee81bd6c210528d7 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 10V, Positive-QTOF | splash10-002b-0059000000-c0053d7ff48e5b7bf21e | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 20V, Positive-QTOF | splash10-05bb-0797000000-ccdaa7ef72717418b1b7 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 40V, Positive-QTOF | splash10-022c-1911000000-a90ad156589941d202e7 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 10V, Negative-QTOF | splash10-0007-0039000000-690e9c11e66c66a1a005 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 20V, Negative-QTOF | splash10-0007-3795000000-80c4a6628c8460481d11 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Arformoterol 40V, Negative-QTOF | splash10-0017-5391000000-9e5db81cdfc6dd49e8ea | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Cazzola M, Matera MG, Lotvall J: Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease. Expert Opin Investig Drugs. 2005 Jul;14(7):775-83. [PubMed:16022567 ]
- Kharidia J, Fogarty CM, Laforce CF, Maier G, Hsu R, Dunnington KM, Curry L, Baumgartner RA, Hanrahan JP: A pharmacokinetic/pharmacodynamic study comparing arformoterol tartrate inhalation solution and racemic formoterol dry powder inhaler in subjects with chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2008 Aug;21(4):657-62. doi: 10.1016/j.pupt.2008.03.003. Epub 2008 Apr 7. [PubMed:18501650 ]
- Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JP: Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. Clin Ther. 2007 Feb;29(2):261-78. [PubMed:17472819 ]
- Donohue JF, Hanania NA, Sciarappa KA, Goodwin E, Grogan DR, Baumgartner RA, Hanrahan JP: Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance. Ther Adv Respir Dis. 2008 Apr;2(2):37-48. doi: 10.1177/1753465808089455. [PubMed:19124357 ]
- Panettieri RA Jr, MacIntyre N, Sims M, Kerwin E, Fogarty C, Noonan M, Claus R, Andrews WT: Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modified-blind, two-way crossover study. Clin Ther. 2009 Aug;31(8):1716-23. doi: 10.1016/j.clinthera.2009.08.012. [PubMed:19808130 ]
- Hanania NA, Donohue JF, Nelson H, Sciarappa K, Goodwin E, Baumgartner RA, Hanrahan JP: The safety and efficacy of arformoterol and formoterol in COPD. COPD. 2010 Feb;7(1):17-31. doi: 10.3109/15412550903499498. [PubMed:20214460 ]
|
|---|